View all cases
UPC CoA 840/2024
Dec 30, 2024·EP3831282 · REMOTE MONITORING OF ANALYTE MEASUREMENTS
- Case details
- StatusCase Closed (Withdrawn)ActionAppealCategoryMain appeal
- Parties
- Claimants
- Dexcom Inc.Operating co.
Representatives- Anne-Charlotte le Bihan-Bird & Bird LLP
- Laurent Labatte-Bird & Bird LLP
- David Sproston-Hoffmann Eitle
- Mark Jones-Hoffmann Eitle
Respondents- Abbott LaboratoriesOperating co.
- Abbott FranceOperating co.
Representatives- Charlotte Garnitsch-Taylor Wessing
- Christian Dekoninck-Taylor Wessing
- François Pochart-August Debouzy
- Wim Maas-Taylor Wessing
- Eelco Bergsma-Taylor Wessing
- Thomas Adocker-Taylor Wessing
- Dietrich Kamlah-Taylor Wessing
- Christian Lederer-Taylor Wessing
- Gisbert Hohagen-Taylor Wessing
- Division
- Court of Appeal
- Technology
- Electrical engineeringDigital communication
- InstrumentsMedical technology
- Language
- English
- First decided
- Jan 24, 2025
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Judge Rian Kalden | Locked |
| Judge Ingeborg Simonsson | Locked |
| Judge Patricia Rombach | Locked |
At the UPC: Dexcom Group (39 cases)·Abbott Group (67 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 3 other proceedings
1 other defendants litigating the same or a related patent
Start a free trial to see how each one ended.
More cases: Court of Appeal·2024
Decisions
- 2025-01-24Application RoP 265Public
Summary: Court of Appeal Panel 2 order permitting DexCom's withdrawal of its infringement appeal and declaring the proceedings closed. Background: the Paris Local Division had revoked EP 3 831 282 (continuous glucose monitoring) and dismissed all DexCom infringement claims; DexCom appealed but then applied to withdraw the action including the appeal. The withdrawal was permitted, proceedings closed, and 60% of appeal court fees refunded to DexCom. No costs decision required.
Show the legal issues (3)
- Withdrawal of infringement action and appeal (R. 265 RoP)
- Reimbursement of court fees (R. 370.9 RoP)
- Continuous glucose monitoring device patents
Documents
| Document title | Date | Public |
|---|---|---|
| Case closed | 2025-09-24 | Not public |
| Headnote-and-Keywords | 2025-01-24 | Not public |
| Outcome of the Order | 2025-01-24 | Not public |
| Reimbursement order | 2025-01-24 | Public |
| Outcome of the Order | 2025-01-24 | Not public |
| Withdrawal order | 2025-01-24 | Public |
| Abbott's comments on withdrawal | 2025-01-21 | Not public |
| Abbott's Comments on withdrawal | 2025-01-21 | Not public |
| Dexcom's comments on withdrawal | 2025-01-20 | Not public |
| Case management order | 2025-01-17 | Not public |
| Receipt | 2025-01-17 | Not public |
| Application for a partial reimbursement of the court fees | 2025-01-17 | Not public |
| Receipt | 2025-01-09 | Not public |
| Consent to Abbott's withdrawal | 2025-01-09 | Not public |
| Receipt | 2025-01-09 | Not public |
| withdrawal application | 2025-01-08 | Not public |
| Panel-Appointment | 2025-01-02 | Not public |
| Receipt | 2025-01-02 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-01-02 | Not public |
| Acknowledgement-of-lodging | 2024-12-30 | Not public |
| 2024 12 30 - UPC CoA - Agreement to file under R.220.2_ | 2024-12-30 | Not public |
| Proof of payment | 2024-12-30 | Not public |
| 2024 12 30 - UPC EP282 Statement of appeal_ | 2024-12-30 | Not public |